Becton Dickinson: Number of Employees 2010-2024 | BDX
Interactive chart of Becton Dickinson (BDX) annual worldwide employee count from 2010 to 2024.
- Becton Dickinson total number of employees in 2023 was 73,000, a 5.19% decline from 2022.
- Becton Dickinson total number of employees in 2022 was 77,000, a 10% increase from 2021.
- Becton Dickinson total number of employees in 2021 was 70,000, a 7.69% increase from 2020.
- Becton Dickinson total number of employees in 2020 was 65,000, a 7.27% decline from 2019.
| Becton Dickinson Annual Employee Count |
| 2023 |
73,000 |
| 2022 |
77,000 |
| 2021 |
70,000 |
| 2020 |
65,000 |
| 2019 |
70,093 |
| 2018 |
76,032 |
| 2017 |
41,933 |
| 2016 |
50,928 |
| 2015 |
49,517 |
| 2014 |
30,619 |
| 2013 |
29,979 |
| 2012 |
29,555 |
| 2011 |
29,369 |
| 2010 |
28,803 |
| 2009 |
29,116 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$69.388B |
$19.372B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
